2-85542588-C-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005911.6(MAT2A):​c.792C>G​(p.Arg264Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.464 in 1,612,940 control chromosomes in the GnomAD database, including 176,804 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 20992 hom., cov: 31)
Exomes 𝑓: 0.46 ( 155812 hom. )

Consequence

MAT2A
NM_005911.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.114

Publications

54 publications found
Variant links:
Genes affected
MAT2A (HGNC:6904): (methionine adenosyltransferase 2A) The protein encoded by this gene catalyzes the production of S-adenosylmethionine (AdoMet) from methionine and ATP. AdoMet is the key methyl donor in cellular processes. [provided by RefSeq, Jun 2011]
MAT2A Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 2-85542588-C-G is Benign according to our data. Variant chr2-85542588-C-G is described in ClinVar as Benign. ClinVar VariationId is 381190.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.114 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.675 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAT2ANM_005911.6 linkc.792C>G p.Arg264Arg synonymous_variant Exon 7 of 9 ENST00000306434.8 NP_005902.1 P31153-1A0A140VJP5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAT2AENST00000306434.8 linkc.792C>G p.Arg264Arg synonymous_variant Exon 7 of 9 1 NM_005911.6 ENSP00000303147.3 P31153-1
MAT2AENST00000409017.1 linkc.603C>G p.Arg201Arg synonymous_variant Exon 7 of 8 1 ENSP00000386353.1 P31153-2
MAT2AENST00000481412.5 linkn.961C>G non_coding_transcript_exon_variant Exon 6 of 7 1

Frequencies

GnomAD3 genomes
AF:
0.513
AC:
77923
AN:
151800
Hom.:
20955
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.681
Gnomad AMI
AF:
0.459
Gnomad AMR
AF:
0.423
Gnomad ASJ
AF:
0.400
Gnomad EAS
AF:
0.391
Gnomad SAS
AF:
0.392
Gnomad FIN
AF:
0.457
Gnomad MID
AF:
0.440
Gnomad NFE
AF:
0.465
Gnomad OTH
AF:
0.507
GnomAD2 exomes
AF:
0.442
AC:
111092
AN:
251118
AF XY:
0.442
show subpopulations
Gnomad AFR exome
AF:
0.685
Gnomad AMR exome
AF:
0.329
Gnomad ASJ exome
AF:
0.403
Gnomad EAS exome
AF:
0.383
Gnomad FIN exome
AF:
0.455
Gnomad NFE exome
AF:
0.467
Gnomad OTH exome
AF:
0.439
GnomAD4 exome
AF:
0.459
AC:
670631
AN:
1461022
Hom.:
155812
Cov.:
42
AF XY:
0.457
AC XY:
332499
AN XY:
726854
show subpopulations
African (AFR)
AF:
0.692
AC:
23144
AN:
33456
American (AMR)
AF:
0.341
AC:
15240
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
0.401
AC:
10469
AN:
26124
East Asian (EAS)
AF:
0.380
AC:
15064
AN:
39688
South Asian (SAS)
AF:
0.393
AC:
33894
AN:
86208
European-Finnish (FIN)
AF:
0.449
AC:
23963
AN:
53416
Middle Eastern (MID)
AF:
0.439
AC:
2532
AN:
5762
European-Non Finnish (NFE)
AF:
0.466
AC:
517893
AN:
1111350
Other (OTH)
AF:
0.471
AC:
28432
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
17877
35754
53631
71508
89385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15416
30832
46248
61664
77080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.514
AC:
78015
AN:
151918
Hom.:
20992
Cov.:
31
AF XY:
0.510
AC XY:
37837
AN XY:
74222
show subpopulations
African (AFR)
AF:
0.682
AC:
28247
AN:
41436
American (AMR)
AF:
0.422
AC:
6436
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.400
AC:
1389
AN:
3470
East Asian (EAS)
AF:
0.391
AC:
2015
AN:
5160
South Asian (SAS)
AF:
0.393
AC:
1893
AN:
4818
European-Finnish (FIN)
AF:
0.457
AC:
4822
AN:
10546
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.465
AC:
31592
AN:
67924
Other (OTH)
AF:
0.509
AC:
1070
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1878
3756
5635
7513
9391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.442
Hom.:
10736
Bravo
AF:
0.517
EpiCase
AF:
0.460
EpiControl
AF:
0.465

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Sep 22, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cardiovascular phenotype Benign:1
Dec 04, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
11
DANN
Benign
0.79
PhyloP100
-0.11
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1078004; hg19: chr2-85769711; COSMIC: COSV52087377; COSMIC: COSV52087377; API